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Background: The optimum timing of cholecystectomy for patients admitted with acute gallbladder 
pathology is unclear. Some studies have shown that emergency cholecystectomy during the index 
admission can reduce length of hospital stay with similar rates of conversion to open surgery, 
complications and mortality compared with a ‘delayed’ operation following discharge. Others have 
reported that cholecystectomy during the index acute admission results in higher morbidity, extended 
length of stay and increased costs. This study examined the cost-effectiveness of emergency versus 
delayed cholecystectomy for acute benign gallbladder disease. 
Methods: Using data from a prospective population-based cohort study examining the outcomes of 
cholecystectomy in the UK and Ireland, a model-based cost–utility analysis was conducted from the 
perspective of the UK National Health Service, with a 1-year time horizon for costs and outcomes. 
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Probabilistic sensitivity analysis was used to investigate the impact of parameter uncertainty on the 
results obtained from the model. 
Results: Emergency cholecystectomy was found to be less costly (£4570 versus £4720; €5484 versus 
€5664) and more effective (0.8868 versus 0.8662 QALYs) than delayed cholecystectomy. Probabilistic 
sensitivity analysis showed that the emergency strategy is more than 60 per cent likely to be cost-
effective across willingness-to-pay values for the QALY from £0 to £100 000 (€0–120 000). 
Conclusion: Emergency cholecystectomy is less costly and more effective than delayed 
cholecystectomy. This approach is likely to be beneficial to patients in terms of improved health 
outcomes and to the healthcare provider owing to the reduced costs. 
 
+A: Introduction 
Contemporary data and meta-analyses1–4 of RCTs have shown that emergency cholecystectomy, 
performed during the index admission, has clinical benefits compared with a ‘delayed’ operation 
following discharge from hospital. Although early surgery has significantly longer operating times, no 
statistical differences have been found for mortality, bile duct injury, bile leakage, conversion to open 
cholecystectomy or overall complications. In addition, patients treated with early surgery have been 
reported to take significantly fewer days off work, have a lower risk of wound infection and a shorter 
hospital stay3. In contrast, other studies5–8 have shown that cholecystectomy during the index acute 
admission results in higher morbidity rates, an extended length of stay and increased costs. Studies that 
have examined cost-effectiveness have consequently reported conflicting results.  
A model-based cost–utility analysis9, using data from a Cochrane review10 including five RCTs 
to describe the probability of different events, found that emergency laparoscopic cholecystectomy for 
acute cholecystitis was less costly (approximately £820 per patient) and resulted in better quality of life 
(+0.05 quality-adjusted life-years, QALYs) than delayed laparoscopic cholecystectomy. It was 
calculated that early laparoscopic cholecystectomy could save £8.5 million per annum. A similar model-
based analysis of emergency cholecystectomy for mild gallstone pancreatitis11 also found the 
emergency procedure to be more cost-effective than cholecystectomy performed later during the same 
admission or at a subsequent admission. In contrast, a study using data from a randomized trial12 showed 
that delaying cholecystectomy was more cost-effective than emergency cholecystectomy.  
Current National Institute for Health and Care Excellence (NICE) guidance13 on gallstone 
disease management used a Markov model to assess the cost-effectiveness of emergency versus delayed 
cholecystectomy in adults with acute cholecystitis and symptomatic bile duct stones; this concluded 
that delayed cholecystectomy was more costly (£958 per patient) and produced more QALYs (+0.005) 
than emergency cholecystectomy. However, the incremental cost-effectiveness ratio (ICER) value was 
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£201 896 per QALY, meaning that a delayed strategy would not be acceptable to healthcare providers. 
Currently NICE guidance13, therefore, recommends emergency cholecystectomy within 1 week of 
diagnosis for patients with acute cholecystitis. 
The CholeS (Clinical Variation in Practice of Cholecystectomy and Surgical Outcomes) study 
was a multicentre prospective, population-based cohort study of variation in practice of 
cholecystectomy in the UK and Ireland undertaken in 201414. The data are representative of current 
practice with robust information on morbidity and mortality related to actual management strategies. 
The aim of the present study was to examine the cost-effectiveness of emergency versus delayed 
cholecystectomy for acute gallbladder disease using data from the CholeS study and other secondary 
sources where necessary. The main endpoint was the QALYs for each approach. 
+A: Methods 
This model-based economic evaluation used data from the CholeS study14 along with further secondary 
sources to inform QALY outcomes. This analysis was carried out from the healthcare provider 
perspective (National Health Service, NHS) in a secondary care (hospital) setting. A 1-year time horizon 
for costs and outcomes was applied, and so discounting was unnecessary. 
+B: CholeS study 
In brief, the CholeS study examined 30-day outcomes for 8909 patients undergoing cholecystectomy 
from 167 hospitals in the UK and Ireland between 1 March and the 1 May 201414. Data were also 
collected on hospital admissions for gallbladder-related diseases in the preceding 12 months and the 
total length of hospital stay accrued in this time frame. Case ascertainment and accuracy of collected 
data was above 95.2 and 98.2 per cent respectively, compared with a 20 per cent sample checked 
independently against the original medical records. Missing data accounted for 0.8 per cent of the data 
set.  
+B: Model structure 
The model structure was developed using TreeAge Pro™ 2016 software (TreeAge Software, 
Williamstone, Massachusetts, USA). This approach was deemed most appropriate taken the short time 
horizon and the lack of recurrence (events occurring in same patients multiple times) in the model.  
The patient group in this analysis was defined as those admitted to hospital as an emergency 
surgical admission with acute gallbladder disease. Two alternative pathways were compared (Fig. 1). 
In the emergency cholecystectomy pathway, cholecystectomy was performed (laparoscopic, 
laparoscopic converted to open or open cholecystectomy) during an emergency surgical admission. In 
the delayed cholecystectomy pathway, patients were admitted as an emergency and subsequently 
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discharged then readmitted for a planned cholecystectomy. These patients were considered in three 
subgroups: successful delayed (no further emergency admissions, with cholecystectomy as an elective 
procedure), unsuccessful delayed with acute surgery (readmission as an emergency with gallstone-
related problems leading to cholecystectomy during that admission), and unsuccessful delayed surgery 
owing to further admissions (readmission as an emergency with gallstone-related problems and 
discharge again with a view to a delayed elective procedure). The procedures and potential 
complications for the delayed pathway following the delayed and emergency events were the same as 
those for the emergency pathway.  
+B: Clinical assumptions 
To implement a model structure that could be generalized, it was necessary to make a number of 
assumptions. First, all complications were considered to have occurred during the inpatient stay 
following cholecystectomy, reflected in the increased costs associated with additional bed days, and the 
impact of these complications on quality of life. Second, for a patient with no complications, there were 
no further outpatient visits. Third, for patients with complications (except bile duct injury), there was 
one further outpatient visit, and for bile duct injury there were four further outpatient visits. Fourth, 
deaths were considered during the hospital stay following cholecystectomy, with deaths occurring at a 
time during the hospital stay equal to the mean(s.d.) length of stay for open cholecystectomy with other 
complications (12.52(0.66) days). Fifth, when patients in the delayed arm were not in hospital they were 
allocated a utility value of 0.77, as used by Wilson and colleagues9, on the basis that utility values for 
patients outside hospital were likely to be higher than those in hospital. (A utility value represents the 
preference of individuals for a desired outcome, and ranges between 0 and 1, where 0 represents death 
and 1 perfect health14.) Finally, the length of stay for patients who had a laparoscopic procedure 
converted to open cholecystectomy was considered to be the same as that of patients having open 
cholecystectomy.  
+B: Probabilities and event timings 
The probabilities of each event in the decision tree were stratified by each of the pathways and informed 
by the CholeS study (Table S1, supporting information).  
To overcome the criticism of previous models regarding failure to integrate length and timing 
of events into the model structure13, data from the CholeS study were used to provide this information 
(Table S2, supporting information). For the emergency pathway, these described the duration of 
preoperative hospital stay and the variable time that could be spent in hospital depending on the 
presence or absence of complications. For the delayed pathway, the data included the duration of 
subsequent admissions, the delay until the patient received an elective cholecystectomy, and the 
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variable length of hospital stays related to emergency re-presentations and complications. The impact 
of the uncertainty of these timings was considered in probabilistic sensitivity analysis (PSA). 
+B: Outcomes 
The primary outcome measure was the QALY, which is a composite measure of the length and quality 
of life; 1 QALY is defined as 1 year lived in perfect health15. Following the approach used by Morris 
and co-workers11 to identify the most appropriate utility values, a review of the Cost-effectiveness 
Analysis Registry was conducted and 20 studies identified9,11,12,16–32. The utility scores in this analysis 
were taken from a single study33 (Table S3, supporting information). This was selected as the utility 
values were obtained using ‘time trade-off’, which is a robust theoretical approach. QALY values were 
obtained by considering the duration of each of the different health states, as informed by the CholeS 
study.  
The utility value for patients in the preoperative phase in the emergency arm was calculated 
using the weighted average of the utilities for acute pancreatitis, biliary colic and acute cholecystitis, 
multiplied by the proportions of the initial patient population that had these conditions. For patients 
who had an emergency admission in the delayed arm, the weighted average of the utility values was 
based on the proportions of those with acute cholecystitis, acute biliary colic and acute pancreatitis.  
+B: Costs and resource data 
All costs in this analysis are described in UK pounds (2013 value), with main results also shown in 
euros (£1 = €1.2; www.bloomberg.com, 25 July 2016), informed by NHS Reference Costs 2013/2014. 
Patients received 1 unit of each cost depending on their pathway; itemized costs are shown in Table S4 
(supporting information). The average cost per patient for a cholecystectomy was based on the cost of 
the procedure itself plus the cost of additional bed days as informed by the CholeS study. Uncertainty 
in the costs incurred per patient was based on the variation in the number of bed days. This uncertainty 
was considered in the PSA. 
+B: Analysis 
The results here are presented using the ICER, defined as the difference in costs between two options 
divided by the difference in QALYs34. 
Probabilistic, one-way and threshold sensitivity analyses were conducted in order to examine 
the robustness of the conclusions drawn from the model to reasonable changes in the model parameters 
and assumptions made. For the PSA, the transition probabilities were described by distributions for 
events which led to two possible outcomes with parameter values calculated by the method of 
moments35, and Dirichlet distributions for three or more outcomes. Utility values were described by 
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distributions as these provide values from 0 to 1 (Table S3, supporting information). Time periods 
were described by  distributions, which provide a value greater than 0 and are right-skewed to allow 
for the possibility of rare events with a long duration (extended periods of hospital stay, waiting times) 
(Table S2, supporting information). For the one-way sensitivity analysis, the following changes to the 
model parameters were examined by assuming that: the initial patient population consisted of only 
patients with acute cholecystitis or acute pancreatitis (these have the same utility value); the initial 
patient population consisted of patients solely with biliary colic; there were no potential emergencies in 
the delayed arm; and all patients experienced a potential emergency admission in the delayed arm.  
Threshold analysis29 was conducted for the probability of a bile duct injury, bile leak and 
common bile duct (CBD) stones in the emergency arm for a laparoscopic cholecystectomy, as this was 
the most common procedure. The threshold for this analysis was defined as the point at which the 
conclusion from the model changed, using a cut-off of £20 000 per QALY (€24 000 per QALY), which 
is at the low end of the threshold of acceptance recommended by NICE. 
+B: Results 
Some 4165 patients had an elective cholecystectomy and were excluded from this analysis. Eighty two  
patients who waited more than 300 days from their index admission and who either initially declined 
surgery or were considered unfit were also excluded from the analysis. Nine patients were excluded 
owing to missing data. Overall, 4653 patients with acute gallbladder disease were included in this 
analysis. They were affected by acute cholecystitis (2125 of 4653), acute biliary colic (1225), acute 
pancreatitis (803) or other acute disorders (such as CBD stones, acalculous cholecystitis or other 
miscellaneous indications; 500 of 4653). 
Emergency cholecystectomy was less expensive and more effective (in terms of QALYs 
gained) than delayed cholecystectomy (Table 1). The mean cost was £4570 (€5484) per patient for the 
emergency strategy and £4720 (€5664) per patient for the delayed strategy. In terms of the effectiveness 
of the two strategies, the emergency pathway resulted in an average QALY gain of 0.8868 per patient, 
whereas the delayed strategy provided an average QALY gain of 0.8662 per patient; the additional 
0.0206 QALYs is equivalent to an extra week of perfect health. 
+B: Sensitivity analysis 
The emergency arm was consistently preferred to the delayed arm (Table 1). The delayed arm was 
found to be more effective (more QALYs gained) than the emergency arm in only one scenario, when 
a preoperative utility of 0.9 was assumed for patients waiting for a procedure in the delayed arm. Even 
under these conditions, the cost per QALY was £38 300 (€45 960), well above the NICE acceptance 
threshold. Only when it was assumed that there were no further emergency readmissions in the delayed 
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arm, was the emergency arm found to be outside the NICE threshold (£36 600 per QALY; €43 920 per 
QALY). 
The results of the PSA are shown in Fig. 2. The cost-effectiveness plane shows the difference 
in costs and QALYs gained for the interventions for each of the 10 000 model runs (Fig. 2a). The points 
are spread in all four quadrants of the cost-effectiveness plane, with 35.2 per cent of the model runs 
showing the emergency strategy to be more effective and less costly than the delayed strategy. This 
finding was reflected in the cost-effectiveness acceptability curve (Fig. 2b); this illustrates the 
proportion of the 10 000 model runs from the PSA that show the emergency and delayed strategies to 
be cost-effective across a range of willingness-to-pay values for the QALY. The emergency strategy 
was more than 60 per cent likely to be more cost-effective than the delayed strategy across all 
willingness-to-pay values for the QALY from £0 to £100 000 (€0–120 000). 
Threshold analysis showed that, following a laparoscopic cholecystectomy in the emergency 
arm, 14.2 per cent of patients would have had to experience a bile duct injury, or 26.5 per cent a bile 
leak, or 39.2 per cent CBD stones, for the delayed arm to become more cost-effective than the 
emergency arm at the acceptance threshold of £20 000 per QALY (€24 000 per QALY). 
+A: Discussion  
This model-based cost–utility analysis, which used a decision tree with a 1-year time horizon to examine 
the impact of emergency versus delayed cholecystectomy for acute gallbladder disease, has clearly 
demonstrated that performing a cholecystectomy during the index emergency admission is more 
effective in terms of QALYs gained and incurs fewer healthcare costs than delayed surgery. Although 
cost savings for each patient may appear small (£150), there is the potential for major savings to the 
healthcare provider over many procedures. Around 70 000 patients have a cholecystectomy in England 
every year and over one-third of these are performed as a delayed procedure. If they were all performed 
as an emergency, the total savings would amount to £3.8 million (€4.56 million). The increase in 
QALYs of 0.0206 for the emergency strategy compared with the delayed strategy equates to more than 
an additional 1 week lived in perfect health, although again this is an average value for all patients, and 
it is unlikely that any single patient would experience this precise QALY gain.  
The results of the PSA support this by showing that across willingness-to-pay values for the 
QALY of £0 to £100 000 (€0–120 000), the emergency cholecystectomy strategy was more than 60 per 
cent likely to be more cost-effective than delayed cholecystectomy. Only for a highly unrealistic 
scenario, with no further emergency events in the delayed arm, was the emergency arm found not to be 
cost-effective. The same was true for the threshold analyses. In all analyses, the threshold values at 
which the delayed arm became the more cost-effective option were highly implausible compared with 
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actual data (for example, the threshold value for bile duct injury was 14.2 per cent, whereas the actual 
rate was 0.1 per cent). 
A key factor that drives these results in favour of emergency surgery is the number of additional 
admissions in the delayed group. In the CholeS study, 32.0 per cent of these patients (1197 of 3740) 
incurred an additional acute admission for a median duration of 9 days. This led to a significant increase 
in costs as well as a temporary reduction in quality of life. The risk of admissions and complications 
while patients are waiting for delayed cholecystectomy is well documented in large population-based 
studies from Canada, the USA and Switzerland36–38. The acute admission rate varies from 19 to 36 per 
cent during the wait for cholecystectomy, compared with a readmission rate of only 4 per cent following 
cholecystectomy37. 
Previous economic analyses of emergency versus delayed cholecystectomy based on RCTs 
may not represent the outcomes seen at a population level39,40. In the present analysis, 
contemporaneously prospectively collected and validated data from the CholeS study were used to 
inform the probabilities of postoperative complications and length of stay. All patients presenting with 
acute biliary disease were included rather than restricting the analysis to one diagnosis, reflecting 
variations seen at a population level. This is a particular strength of this study, which is pragmatic and 
generalizable. Patients with acute gallbladder disease use the same resources (surgical admission, 
diagnosis and surgery) and it is therefore important that future pathways are developed to treat the whole 
spectrum of acute gallbladder disease, rather than focusing on a narrow diagnostic category. 
 Patients who had gallbladder-related hospital admissions more than 1 year previously were not 
included in this study, as these are likely to be very rare and are unlikely to have affected the results. 
The time horizon here was limited to 1 year in line with previous studies9,11.  Although this may have 
led to the under-reporting of long-term complications, such as CBD stones or strictures41, there is no 
evidence of an increased rate of long-term complications in the emergency arm. Given the robustness 
of the results from this analysis to reasonable changes in parameter values, it seems unlikely that a late 
event would have had significant impact on the conclusions drawn. No data were available for patients 
who had cholecystostomy to drain the gallbladder before delayed or emergency surgery. Although this 
is likely to compromise quality of life, it is a rare event42, and also unlikely to have affected the present 
results. 
Hospitals that are not yet providing sufficient emergency cholecystectomy services will find 
there are initial set-up costs associated with providing additional emergency care for these patients. 
These may include costs of improving the diagnostic pathway (extra ultrasound lists), access to the 
operating theatre (additional emergency theatre lists) and administration of the emergency pathway. 
Although the present study does not directly account for these set-up costs, it can nevertheless be seen 
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that cost savings can be made by improving the rates of emergency surgery among patients with acute 
gallbladder disease. 
The results of the present study are similar those of the two previous studies that used a model-
based cost–utility analysis conducted in a UK NHS setting. In a study that examined emergency versus 
delayed cholecystectomy among patients with acute cholecystitis9, emergency surgery was less costly 
(£2574 versus £3396; 2006 prices) and more effective (0.8765 versus 0.8250 QALYs gained). 
Similarly, a study involving patients with mild acute gallstone pancreatitis11 reported that laparoscopic 
cholecystectomy within 3 days of the index admission was less costly than operations delayed beyond 
that time or surgery during a later elective admission (€2748 versus €3543 versus €3752, 2011–12 
prices) and at least as effective (0.888 versus 0.888 versus 0.884 QALYs gained).  
The CholeS study evaluated the practice of emergency cholecystectomy for acute gallbladder 
diseases across UK and Ireland43. Despite the weight of evidence supporting the use of emergency 
cholecystectomy for most patients presenting acutely with biliary colic, cholecystitis or gallstone 
pancreatitis, there was still marked variation in the rate of emergency cholecystectomy across the 166 
hospitals included in the CholeS study44,45. There was significant variation owing to patient (age, certain 
indications, need for further radiological imaging and interventions) and hospital (admission to a 
specialist hepatopancreatobiliary centre) factors. Provider-level strategies need to be investigated to 
increase the numbers of emergency cholecystectomies performed. 
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NHS Foundation Trust); V. Chitre, K. Aryal, P. Ferris (Paget University Hospitals NHS Foundation 
Trust); M. Silva, S. Lammy, S. Mohamed, A. Khawaja, A. Hussain, M. A. Ghazanfar, M. I. Bellini 
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Typesetter: please refer to marked-up figures 
Fig. 1 Emergency and delayed cholecystectomy pathways. A and B are event nodes describing types 
of operation and outcomes following surgery respectively. CBD, common bile duct 
Fig. 2 a Cost-effectiveness plane showing the results of probabilistic sensitivity analysis for 10 000 
model runs with the delayed pathway as the reference strategy; b cost-effectiveness acceptability 
curve showing the results of the probabilistic sensitivity analysis across a range of willingness-to-pay 
thresholds. QALY, quality-adjusted life-years 
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Table 1 Results of one-way sensitivity analysis  
 
Strategy 
Cost 
(£) 
Incremental 
cost (£) 
Effectiveness 
(QALYs) 
Incremental 
effectiveness 
(QALYs) 
ICER 
(£/QALY) 
Baseline      
Emergency 4570 0 0.8868 0  
Delayed 4720 150 0.8662 –0.0206 Dominated* 
Delayed arm – preoperative utility = 0.6   
Emergency 4570 0 0.8868 0  
Delayed 4720 150 0.8343 –0.0525 Dominated* 
Delayed arm – preoperative utility = 0.8    
Emergency 4570 0 0.8868 0  
Delayed 4720 150 0.8719 –0.0149 Dominated* 
Delayed arm – Preoperative utility = 0.9    
Emergency 4570 0 0.8868 0  
Delayed 4720 150 0.8907 0.0039 38 300 
No potential emergencies in delayed arm 
Delayed 3810 0 0.8659 0 0 
Emergency 4570 760 0.8868 0.0209 36 600 
All delayed patients experience a potential emergency   
Emergency 4570  0.8868   
Delayed 6660 2090 0.8669 –0.0199 Dominated* 
Costs are rounded to the nearest £10, and incremental cost-effectiveness ratio (ICER) values to the 
nearest £100. *An intervention that is more costly and less effective than the comparator. 
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